Role of MTHFR genetic polymorphisms in the susceptibility to childhood acute lymphoblastic leukemia.
The central role of methylenetetrahydrofolate reductase (MTHFR) in the folate metabolism renders MTHFR gene polymorphisms (C677T and A1298C) potential modulators of a variety of disorders whose development depends on folate/homocysteine imbalance. Here, we provide additional evidence on the protective role of these polymorphisms in acute lymphoblastic leukemia (ALL), the most common pediatric cancer. A case-control study was conducted in 270 ALL patients and 300 healthy controls of French-Canadian origin. The TT677/AA1298 and CC677/CC1298 individuals were associated with reduced risk of ALL (crude odds ratio [OR] = 0.4; 95% confidence interval [CI], 0.2-0.9; and OR = 0.3; 95% CI, 0.1-0.6; respectively). Further stratification in patients born before and after January 1996 (approximate time of Health Canada recommendation for folic acid supplement in pregnancy) revealed that the protective effect of MTHFR variants is accentuated and present only in children born before 1996. Similar results were obtained when a transmission disequilibrium test was performed on a subset of children (n = 95) in a family-based study. This finding suggests gene-environment interaction and its role in the susceptibility to childhood ALL, which is consistent with previous findings associating either folate deficiency or MTHFR polymorphisms with risk of leukemia.
Krajinovic
Maja
M
Centre de recherche, Hôpital Sainte-Justine, Montréal, QC, Canada.
Lamothe
Stephanie
S
Labuda
Damian
D
Lemieux-Blanchard
Emilie
E
Theoret
Yves
Y
Moghrabi
Albert
A
Sinnett
Daniel
D
D016022:Case-Control Studies; D002675:Child, Preschool; D005260:Female; D005494:Folic Acid Deficiency / Q000150:complications; D005838:Genotype; D006801:Humans; D008297:Male; D042965:Methylenetetrahydrofolate Reductase (NADPH2) / Q000235:genetics*; D011110:Polymorphism, Genetic; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000201:enzymology* / Q000209:etiology / Q000235:genetics*; D012307:Risk Factors
D042965:Methylenetetrahydrofolate Reductase (NADPH2)